Evidence map›Paper›PMID 23625731›Full record

ArticlePharmacotherapy2013

Psychologic disorders and statin use: a propensity score-matched analysis.

Ishak Mansi, Christopher R Frei, Mary J Pugh, Eric M Mortensen

Abstract read
In one paragraph

Article in Pharmacotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Statins, mood, sleep, and physical function: a systematic review.European journal of clinical pharmacology · 2014
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. A conceptual framework for evaluating data suitability for observational studies.Journal of the American Medical Informatics Association : JAMIA · 2018
    Article
  8. Review
  9. Observational
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ishak MansiBrooke Army Medical Center, San Antonio, Texas, USA. ishak.mansi@va.gov
Christopher R Frei
Mary J Pugh
Eric M Mortensen

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2RR025766 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A · 2008 to 2011
$1.7M
NCRR NIH HHS KL2 RR025766NIAID NIH HHS L30 AI066658
6 · The paper itself

Abstract

STUDY

objectiveTo evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population.

designRetrospective, observational, population-based, propensity score-matched, cohort study.

settingDatabase of a patient population enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus. PATIENTS: Medical records were reviewed from 46,249 patients aged 30-85 years who were continuously enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus from October 1, 2003-March 1, 2010. Data were obtained from the Military Health System Management Analysis and Reporting Tool (M2). Based on drug fills during fiscal year 2005, patients were stratified as statin users (13,626 patients received at least 90-days supply of statin) or nonusers (32,623 patients never received a statin during the study period). A propensity score-matched cohort of 6972 statin users and 6972 nonusers from this population was created. MEASUREMENTS AND MAIN

resultsThe occurrence of psychologic disorders between October 1, 2005, and March 1, 2010, was determined using prespecified groups of ICD-9-CM, Psych1: schizophrenia, schizoaffective disorders, and other psychosis; Psych2: major depression and bipolar disorder; Psych3: all psychologic disorders as identified by the Agency for Health Research and Quality-Clinical Classifications (except for categories of childhood or developmental psychiatric disorders). Between matched pairs of statin users and nonusers, the odds ratios and 95% confidence intervals were as follows: Psych1 (0.9, 0.75-1.05), Psych2 (1.02, 0.94-1.11), and Psych3 (1.02, 0.96-1.1), respectively.

conclusionThe risk of developing psychologic disorders was similar in this cohort of propensity score-matched statin users and nonusers.

Indexed as

Military PersonnelAdultAgedAged, 80 and overCohort StudiesDatabases, FactualFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMental DisordersMiddle AgedPropensity ScoreRetrospective StudiesTexasHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID23625731
PMCPMC3676864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.